| abstract |
A compound of formula (I) Pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising such compounds, methods of treating cystic fibrosis using the compounds, and methods of making the compounds are also disclosed. Also disclosed are solid state forms of Compound 1 and salts and solvates thereof. |